These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 28398345)

  • 1. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
    Kim D; Lim K; Kim ST; Yoon SH; Kim K; Ryu SM; Kim JS
    Nat Biotechnol; 2017 May; 35(5):475-480. PubMed ID: 28398345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion.
    Zong Y; Wang Y; Li C; Zhang R; Chen K; Ran Y; Qiu JL; Wang D; Gao C
    Nat Biotechnol; 2017 May; 35(5):438-440. PubMed ID: 28244994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient RNA-guided base editing in mouse embryos.
    Kim K; Ryu SM; Kim ST; Baek G; Kim D; Lim K; Chung E; Kim S; Kim JS
    Nat Biotechnol; 2017 May; 35(5):435-437. PubMed ID: 28244995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion.
    Shimatani Z; Kashojiya S; Takayama M; Terada R; Arazoe T; Ishii H; Teramura H; Yamamoto T; Komatsu H; Miura K; Ezura H; Nishida K; Ariizumi T; Kondo A
    Nat Biotechnol; 2017 May; 35(5):441-443. PubMed ID: 28346401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide specificity of dCpf1 cytidine base editors.
    Kim D; Lim K; Kim DE; Kim JS
    Nat Commun; 2020 Aug; 11(1):4072. PubMed ID: 32792663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide target specificity of CRISPR RNA-guided adenine base editors.
    Kim D; Kim DE; Lee G; Cho SI; Kim JS
    Nat Biotechnol; 2019 Apr; 37(4):430-435. PubMed ID: 30833658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.
    Kim YB; Komor AC; Levy JM; Packer MS; Zhao KT; Liu DR
    Nat Biotechnol; 2017 Apr; 35(4):371-376. PubMed ID: 28191901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.
    Kim D; Kang BC; Kim JS
    Nat Protoc; 2021 Feb; 16(2):1170-1192. PubMed ID: 33462439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.
    Kim D; Kim J; Hur JK; Been KW; Yoon SH; Kim JS
    Nat Biotechnol; 2016 Aug; 34(8):863-8. PubMed ID: 27272384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
    Komor AC; Kim YB; Packer MS; Zuris JA; Liu DR
    Nature; 2016 May; 533(7603):420-4. PubMed ID: 27096365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.
    Kim D; Bae S; Park J; Kim E; Kim S; Yu HR; Hwang J; Kim JI; Kim JS
    Nat Methods; 2015 Mar; 12(3):237-43, 1 p following 243. PubMed ID: 25664545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9
    Li Q; Seys FM; Minton NP; Yang J; Jiang Y; Jiang W; Yang S
    Biotechnol Bioeng; 2019 Jun; 116(6):1475-1483. PubMed ID: 30739328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbiased investigation of specificities of prime editing systems in human cells.
    Kim DY; Moon SB; Ko JH; Kim YS; Kim D
    Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Genome-Wide Specificity of dCpf1 Cytidine Base Editors Using Digenome-Seq.
    Kim D
    Methods Mol Biol; 2023; 2606():33-40. PubMed ID: 36592306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylase base editors enable C-to-A and C-to-G base changes.
    Zhao D; Li J; Li S; Xin X; Hu M; Price MA; Rosser SJ; Bi C; Zhang X
    Nat Biotechnol; 2021 Jan; 39(1):35-40. PubMed ID: 32690970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
    McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
    Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of high-precision base editors for site-specific single nucleotide replacement.
    Tan J; Zhang F; Karcher D; Bock R
    Nat Commun; 2019 Jan; 10(1):439. PubMed ID: 30683865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.